
- Sensors input: ECG, BP, BIA
- SpO₂, skin temperature, motion
- Questionnaire (lifestyle)
NeuTigers.aiNeural intelligence.SWEETDEEP™ · CONSUMER WELLNESS
SweetDeep turns everyday wearable signals into metabolic-wellness insights that support healthy habits — and healthy lifestyle choices may help reduce the risk of type 2 diabetes. Designed to meet people where life happens.

OVERVIEW & WELLNESS EXPERIENCE
Daily free-living data collection, insight at the point of use, and personal recommendations that support behavior change.




BENEFITS
SweetDeep is being developed as a general wellness experience for its initial consumer launch.
CONSUMER WELLNESS STATUS
The initial consumer launch is a general wellness experience; screening claims are investigational and pursued with partners through regulated pathways.
CURRENT STATUS
SAMSUNGSuccessful proof-of-concept completed with Samsung on Galaxy Watch.
✓
DEVICE APPSSweetDeep™ prototype apps available on Android and Wear OS platforms.
✓
FDAFDA Breakthrough Device Designation, submitted June 2026, not yet granted.
✓
READYReady to engage in strategic pilots and commercial discussions with partners.
✓PRODUCT FAQ
Short answers on what SweetDeep is — and what it is not.
No. SweetDeep is being developed as a general wellness experience for its initial consumer launch; general wellness products are not medical devices and are not reviewed by FDA. It is not intended to diagnose, treat, cure or prevent any disease.
It turns everyday wearable signals (ECG, PPG/BP, BIA and lifestyle context) into metabolic-wellness insights, a daily score and personalized recommendations that support healthy habits — and healthy lifestyle choices may help reduce the risk of type 2 diabetes.
SweetDeep prototype apps are operational on Android and Wear OS, with a completed proof-of-concept on Samsung Galaxy Watch.
Inference runs on-device with Edge-AI; the experience is designed to be privacy-preserving, with no transmission of raw biometric data.
SweetDeep is in active development toward its consumer wellness launch. Screening capabilities for professional channels are investigational and subject to regulatory authorization.
Regulatory disclaimer: SweetDeep is being developed as a general wellness experience for its initial consumer launch; general wellness products are not medical devices and are not reviewed by FDA. It is not intended to diagnose, treat, cure or prevent any disease. Screening and clinical capabilities described for professional audiences are investigational and subject to regulatory authorization.
EXPERIENCE SWEETDEEP